HUTCHMED (China) (HCM) Return on Invested Capital (2018 - 2021)
HUTCHMED (China) (HCM) reported Return on Invested Capital of 0.01% for Q4 2021, down 33.47% quarter-over-quarter from 0.01% in Q2 2021.
HUTCHMED (China) (HCM) Return on Invested Capital (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2021.
- Return on Invested Capital for Q4 2021 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.22%, up 22.0% from the prior year.
- Return on Invested Capital slipped to 0.01% in Q4 2021 per HCM's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.01% in Q1 2021 and troughed at 0.2% in Q2 2019.
- A 3-year average of 0.03% and a median of 0.0% in 2019 frame the typical range for Return on Invested Capital.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.00% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 0.01% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 0.00% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.00% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 0.00% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 0.00% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.00% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 0.00% |
| 10 | HUTCHMED (China) | 1.20 Bn | -273.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.01% |
| Jun 30, 2019 | -0.20% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |